Optibiotix Health Share Discussion Threads

[judijudi] 05/5/2017 14:58

Ramos,
All buys today?

[parob] 05/5/2017 14:47

Good work as always Elric.I see SBTX has made a comeback today despite 'being hammered' earlier. Just my opinion but I think we've hit the bottom on both OPTI and SBTX today.As I've mentioned before this can rise just as quickly as it's fallen, with the right news and sentiment.

[ramas] 05/5/2017 14:38

All buys today ... not all showing maybe selling almost done ?

[slartybartfaster] 05/5/2017 13:02

I got the impression a lot are impatient pi selling and some may be shorts. There is a lot in the pipeline to make this bounce and if there is short interest it is dangerous in any illiquid company.

[slartybartfaster] 05/5/2017 12:53

sorry manc i wasnt aware of the football connection. Both looking up to us :)

[riskybusiness1] 05/5/2017 12:52

I agree. If these 10,000 are shorts then once this starts heading back north they will have to cover pretty sharpish.

[elrico] 05/5/2017 12:45

Risky - It is a fact investors see opportunities ahead of others, it is also a fact some just don't see new areas of opportunities, not because they have not looked, there are many reasons; mainly they don't have the foresight, business acumen,and or simply don't understand the company strategy or science. That all fine, it's what makes a market opportunity for those of us that do understand, all we need is patience.

The jam tomorrow or market cap jibs have a shelf life, the use by date is closing in.

[manc10] 05/5/2017 12:37

slarty from a blue is mcfc to a red is mufc elric watches united I watch city

[riskybusiness1] 05/5/2017 12:35

If skin 4 bags which I agree will happen, optis holding grows to £20m..... how are you working these things out

[manc10] 05/5/2017 12:30

just got the investors chronicle . headlines on the front page , medicine for the new world , goes through different company profiles of which drugs they are creating for different life style illnesses , optis launch is mentioned saying this has the capacity to lower cholesterol and high blood pressure its a nice size article so a bit more publicity

[riskybusiness1] 05/5/2017 12:21

The jam tomorrow comments are getting old now as opti is proving it can bring these great patent protected ideas from concept to market. In under 3 years from listing the pipeline has grown and the products are out next week. Any one of these products could seriously make opti profitable in the next few years. If you really take the time to look and see the opportunity and contrast this with the stable 80-100k costs you realise there a lot to come when these sales get built and the products established.

[loveandmoney1] 05/5/2017 12:13

bit of advice,and last correspondence with the angry man

dump this and buy SBTX

this will halve
that will likely 4 bag.



till next time.atb

[slartybartfaster] 05/5/2017 12:09

red to blue you stupid manc keep up. at least elrico offers something other than on liners and silly girly comments about market cap when they know nothing about building a business. Yes you lovely, stupid girl.

[slartybartfaster] 05/5/2017 11:58

Outstanding again elrico

monkeywench id be more concerned with your biome jam tomorrow compnay if i were you. it seems to have took a mighty tumble in the face of q1 sales increasing from 55k to 800k. It seems the market is spooked about something there. Ill have a look at for you later and see what I can find. You are no so good an data mining it would appear. To many on liners cluttering up the single cell.

[loveandmoney1] 05/5/2017 11:57

expensive jam

pay now get it delivered in@5 years........

[bobdown2] 05/5/2017 11:55

Thanks elrico. The fincap part adds reassurance.

[manc10] 05/5/2017 11:54

from a blue to a red keep up the great work elrik

[loveandmoney1] 05/5/2017 11:51

"Any casual observer would see that the revenue we would need to achieve a valuation of £60m+ are eminently achievable in just one division in the next few years"

eminently.....in a few years.....

and it is valued at @£70m now...


o dear.

[pglancy] 05/5/2017 11:44

elrico job

I am sure we have all been scratching our heads since the retracement from recent 90p intra. I am no different. I offered the following to concerns to SOH, mainly in the hope he listens to my concerns, our concerns as I see them. As I put them to SOH as part of an editorial, if you like for a later date.

I did not expect a response at this stage.

In no particular order, issues as I see them that have had a negative impact on the company(s);

1 - Confusion around the SBTX distributions, qualifying date and ex divi date

2 - Assumption GoFigure will not be in an major UK retailer due marketing expenditure THWLC would be expected to contribute to, which flies in the face of the OPTI business model

3 - Concerted short action - there has been a consistent 10k short action every day

4 - Possibly the most important - No revenue guidance from sales. Personally, I fully understand why there is none at this stage. However, I hope there could be some guidance as and when LP-LDL is launched because LP-LDL is seen as a pivotal product launch where most PI's have been very patient and very optimistic.





Thanks Elric,
Our emails crossed over as I sent a quick response last night whilst travelling. I always value your insight and agree with the issues. Just to help in terms of guidance:-

1. We have always made clear our approach to SBTX which was outlined in my presentations at the Investor Show and recent investor meeting
a. Our focus is on building value in SBTX
b. Our aim is release value back to shareholders without unduly impacting on both SBTX and OPTI value
c. We are working on the best way of achieving this with our advisors
d. We hope to have the details worked out in the near future and announced so shareholders will see how they can benefit
2. This is a false assumption as we are speaking to a number of major retailers and fully expect a listing in at least one. The key point which has been lost in translation is that we need to support any retail listing with marketing expenditure to ensure we maximise product exposure. This needs proper planning with the retailers who charge you for space in store, promotions (typically seasonal), to maximise our return. We do not see getting a retail listing as a hurdle but need to do it properly. This means ensuring our supply chain can meet the high volumes, scheduling production, filling, and packaging runs, and renegotiating with suppliers (or changing suppliers) to obtain a lower cost of goods at the substantially higher volumes to ensure we maintain product margins. That is part of sensible business which is structured to build long term value and not feed market hype.
3. Agree. (EDIT – SOH also put this down to a lot of retail PI's selling. His source Finncap)
4. Agree. I started to give indications of potential in the presentation and most importantly link this to industry multiples and market valuations. Any casual observer would see that the revenue we would need to achieve a valuation of £60m+ are eminently achievable in just one division in the next few years. When you combine our product launch last year of GoFigure, our forthcoming LP-LDL launch, an dour launch of SweetBiotix later this year most observers will see if the potential for an upside.

Keep up the good work and please feel free to share as all this information is either our annual report or was provided at the presentation.



Best Wishes,

Stephen OHara

[incanus] 05/5/2017 11:42

Looks like facts to me you idiot.

[incanus] 05/5/2017 11:40

Great response elric. Thanks for taking the time to on this. I was getting really nervous, still am but feel better now. Still not clear about the sbtx shares though.

[monkeywench1] 05/5/2017 11:39

All this ramping is adding to the jam tomorrow scenario.

[elrico] 05/5/2017 11:29

I am sure we have all been scratching our heads since the retracement from recent 90p intra. I am no different. I offered the following to concerns to SOH, mainly in the hope he listens to my concerns, our concerns as I see them. As I put them to SOH as part of an editorial, if you like for a later date.

I did not expect a response at this stage.

In no particular order, issues as I see them that have had a negative impact on the company(s);

1 - Confusion around the SBTX distributions, qualifying date and ex divi date
 
2 - Assumption GoFigure will not be in an major UK retailer due marketing expenditure THWLC would be expected to contribute to, which flies in the face of the OPTI business model
 
3 - Concerted short action - there has been a consistent 10k short action every day
 
4 - Possibly the most important - No revenue guidance from sales. Personally, I fully understand why there is none at this stage. However, I hope there could be some guidance as and when LP-LDL is launched because LP-LDL is seen as a pivotal product launch where most PI's have been very patient and very optimistic.





Thanks Elric,
Our emails crossed over as I sent a quick response last night whilst travelling.  I always value your insight and agree with the issues.  Just to help in terms of guidance:-
 
1.      We have always made clear our approach to SBTX which was outlined in my presentations at the Investor Show and recent investor meeting
a.      Our focus is on building value in SBTX
b.      Our aim is release  value back to shareholders without  unduly impacting on both SBTX and OPTI value
c.      We are working on the best way of achieving this with our advisors
d.      We hope to have the details worked out in the near future and announced so shareholders will see how they can benefit
2.      This is a false assumption as we are speaking to a number of major retailers and fully expect a listing in at least one.  The key point which has been lost in translation is that we need to support any retail listing with marketing expenditure to ensure we maximise product exposure.  This needs proper planning with the retailers who charge you for space in store, promotions (typically seasonal), to maximise our return. We do not see getting a retail listing as a hurdle but need to do it properly.  This means ensuring our supply chain can meet the high volumes, scheduling production, filling, and packaging runs, and renegotiating with suppliers (or changing suppliers)  to obtain a lower cost of goods at the substantially higher volumes to ensure we maintain product margins.  That is part of sensible business which is structured to build long term value and not feed market hype.
3.      Agree.  (EDIT – SOH also put this down to a lot of retail PI's selling. His source Finncap)
4.      Agree.  I started to give indications of potential in the presentation and most importantly link this to industry multiples and market valuations.  Any casual observer would see that the revenue we would need to achieve a valuation of £60m+ are eminently achievable in just one division in the next few years.  When  you combine our product launch last year of GoFigure, our forthcoming LP-LDL launch, an dour launch of SweetBiotix later this year most observers will see if the potential for an upside.
 
Keep up the good work and please feel free to share as all this information is either our annual report or was provided at the presentation.
 
 
 
Best Wishes,
 
Stephen OHara

[john henry] 05/5/2017 10:57

As i said the other day the selling volume isnt heavy its just that there is next to no buying and in a market that at the moment doesnt want stock the only direction is down. Its the lack of demand for stock that is killing the price.

[talkingtrade] 05/5/2017 10:49

SBTX taking a hammering